Laserfiche WebLink
The Economist April loth zozr <br />Covid-ug vaccines <br />Sorting signal <br />from noise <br />With millions vaccinated, rare side- <br />effects of covid jabs are coming to light <br />CHR[s wHrrrY, England's chief medical <br />officer, vividly recalls a nerve-raciaog <br />moment on December 8th 2020. That was <br />the day when England became the first <br />country to roll out a covid-r9 vaccine, a jab <br />developed by Pfizer and BioNTech. Near <br />in idWght on vaccination day one "we were <br />discussing it and just thinking 'what are <br />we dealing with here? These are small <br />numbers and we've already had several <br />dangerous near misses'.- said Dr Whitty in <br />a recent talk at the Royal Society of Medi- <br />ae. In somepcople, it had turned out, the <br />vaccine sets off anaphylaxis, a life-threat- <br />ening <br />fe-threatening allergic reaction. But this is rare. It <br />occurred just once among the 22,000 or so <br />people vaccinated in the trial. which could <br />have been by chance. Now, with hundreds <br />of millions vaccinated, the rate at which it <br />occurs is cleaner: five per million. <br />Fortunately, this side-effect is not only <br />extremely rare but shows up soon after the <br />jab. And treatment for it exists. Everyone <br />who receives the Pflrxr vaccine is now <br />asked to stidcaround fuorc5 minutes, just in <br />case. There have been no deaths from ana- <br />phylaxis related to the vaccine <br />As millions of jabs of various covid-tg <br />vaccines are administered every day, such <br />rare adverse reactions will inevitably <br />emerge. On April 7th both Britain's health <br />officials and the European Medicines <br />Agency (caw), which regulates drugs in the <br />European Union. said there is strong evi- <br />dence that AstraZeneca's covid-r9 vaccine <br />may be unload with very tare blood clots, <br />often in the brain or the abdomen. The Em <br />expects reached their conclusion based on <br />a review of 86 reported cases, r8 of which <br />were fatal. Britain's experts reached the <br />same conclusion from data on 79 cases, h9 <br />of which were fatal. Both the FmA and Brit- <br />ain's drug regulator concluded that the <br />vaccines benefits outweigh the potential <br />risk of the dots. But Britain's officials, <br />armed as usual with some nifty charts for <br />their televised briefing, said thatforpeople <br />under ;o the risks and benefits from the <br />vaccine were 'finely balanced", so a differ- <br />ent jab may be preferable. <br />The investigation of the suspected clots <br />from the Astra7eneca jab has been a prime <br />exampleofrhe challenge ofsortingthe sig- <br />nal of a vaccine's side-effects from the ca- <br />cophony of medical emergencies that hap- <br />pen to millions of people every day. Vac- <br />cine -safety experts have two ways to un- <br />lve whether a rare medical proh]em is <br />Pla� at work <br />caused by a vaccine, says lcathryn Edwards <br />of the Vanderbilt University school of <br />Medicine, In Nashville, Tennessee. They <br />can compare its rate in vaccinated people <br />against the `background' rates ofit thatare <br />observed in the unvaccinated. And they <br />an look for unusual features of the medi- <br />cal condition being investigated_ <br />The fust signals emerged in late Febru- <br />ary, when doctors in several European <br />countries noticed clusters of blood dots In <br />people recently given the AstraZeneca jab, <br />someofwhom died- Most were women un- <br />der 6o, which was not terribly surprising <br />because many EU countries were, at first, <br />not convinced that the jab worked in the el- <br />derly and used it largely for essential work- <br />ers, such as nurses, teachers and social - <br />care workers—professions in which most <br />employees are women. <br />The FMA's data as of March 22nd sug- <br />gested that the tate of brain clots in people <br />under the age of 6o who bad bad Astra- <br />Zenecas vaccine was one in hoo,000— <br />higher than would be expected normally. <br />Precisely how much higher, though, is <br />hard to tell. The rates of such rareand diffi- <br />cuit-to-diagnose conditions vary a lot by <br />country, age and sex. Estimates of the inci- <br />dence of such brain dots have ranged from <br />0.22 to 1.57 cases per too,000 people per <br />year, and they, are more common in youn- <br />gerpeopleand women. <br />As doctors began to look more closely, <br />something curious emerged Many pa- <br />tients with suspected clots from the vac- <br />cine had unusually low levels of platelets. <br />These are fragments of special precursor <br />cells that float in the blood Their job is to <br />form blood clots (they rush to the site of a <br />ort or other bleeding). Cow platelet levels <br />therefore usually result in uncontrolled <br />bleeding, not dots. <br />Comments on the Draft CAP 2.0 <br />2021.12.22 <br />Science & technology 73 <br />with this new information to hand, <br />Britain's medical regulators searched their <br />data on vaccinated people for the unusual <br />tandem of clots and low platelet counts. <br />They found four cases per million people <br />vaccinated, a rate several times lower than <br />in the EU. One explanation is that Britain, <br />unlike the rest of Europe, had used the jab <br />primarily in older people. The rateat which <br />the clots occurred in Britain declined <br />steadily with age. importantly, Britain's ex- <br />perts found that the clots occurred as <br />much in men as they did in women. <br />This combination of blood dots and <br />low platelet counts is something that doc- <br />tors know bow to diagnose and treat, says <br />Jean Marie Connors, a haematologist at <br />Brigham and women's Hospital, in Boston. <br />It resembles a condition seen is some peo- <br />ple who are given heparin, a drug used <br />widely to treat blood dots. For unknown <br />reasons, some people develop an immune <br />reaction to heparin, which results in blood <br />dotting so profound that it depletes their <br />platelets. The same reaction appears to be <br />provoked by the vaccine. <br />Medical societies in several countries <br />have already issued guidelines to doctors <br />on how to spot and treat this rare reaction <br />to the AstraZeneca vaccine. With vigilance <br />and appropriate care, the extremely rare <br />deaths that may result from it will become <br />even rarer a <br />Dorn-ast3c hcating <br />A new use for <br />microwaves <br />U you can have microwave ovens, why <br />rot microwave boilug <br />DECARBONISING AN BODNOMY i5 a big <br />job. Coal- and gas -fined power plants <br />must be swapped for wind, solaror nuclear <br />ones. Petrol -driven cars must be replaced <br />by electric versions. Less attention is paid <br />to beating. But in cold countries such as <br />Britain, warming houses, offices and the <br />like consumes more fossil fuel than etcher <br />electricity generation or transport <br />The fuel involved is usually natural gas. <br />This is burned in aceatral boilerin orderto <br />heat water that flows to radiators else- <br />where in the building. Britain's govern- <br />ment would like to change this. From 2025 <br />gas -fined boilers will be banned in newly <br />built homes. By the mid-2o3os installing <br />new gas boilers in existing houses will be <br />banned, too. <br />The question Is what will replace them. <br />Unlike electricity generation, where re- <br />newables are proving popular, or ars, <br />where battery -powered vehicles are rapid- <br />ly becoming established, the market for �► <br />